There are 18 resources available
Update on the Clinical Efficacy of Approved Targeted Agents: Formal Indications, Efficacy and Toxicity
Presenter: S. Loges, DE
Session: Session 3 – Molecular Target / Family of Targets – Rare EGFR
Resources:
Slides
Webcast
Testing for the Target / Biomarker (Assays, Technicalities and Practicalities, Challenges for Interpretation)
Presenter: A. Stenzinger, DE
Session: Session 3 – Molecular Target / Family of Targets – Rare EGFR
Resources:
Slides
Webcast
A Clinicopathological Case Presented and Discussed by a Molecular Tumour Board
Presenter: S. Loges, DE
Session: Session 3 – Molecular Target / Family of Targets – Rare EGFR
Resources:
Slides
Webcast
Value / Health Economics of Testing and Targeting (incl. MCBS, ESCAT Actionability, RWD)
Presenter: A. Kron, DE
Session: Session 4 – Precision Oncology From the Perspective of Health Economics
Resources:
Slides
Webcast
Biology of the Target / Biomarker (Function and Roles in Normal and Tumour Tissue Homeostasis)
Presenter: F. López-Ríos, ES
Session: Session 5 – Molecular Target / Family of Targets – RET
Resources:
Slides
Webcast
Update on the Clinical Efficacy of Approved Targeted Agents: Formal Indications, Efficacy and Toxicity
Presenter: J. Wolf, DE
Session: Session 5 – Molecular Target / Family of Targets – RET
Resources:
Slides
Webcast
Testing for the Target / Biomarker (Assays, Technicalities and Practicalities, Challenges for Interpretation)
Presenter: F. López-Ríos, ES
Session: Session 5 – Molecular Target / Family of Targets – RET
Resources:
Slides
Webcast
A Clinicopathological Case Presented and Discussed by a Molecular Tumour Board
Presenter: J. Wolf, DE
Session: Session 5 – Molecular Target / Family of Targets – RET
Resources:
Slides
Webcast